Patient's question:
Baby born 10 days, jaundice value, forehead is 8.5 mg/dL, cheeks are 13.4, chest is 14.6Doctor's answer:
Analysis of the condition: Neonatal jaundice refers to the yellowing of the skin, sclera, and mucous membranes in newborns, also known as neonatal hyperbilirubinemia. Its etiology is specific and complex, and severe cases can lead to bilirubin encephalopathy (kernicterus), often resulting in death and severe sequelae. Neonatal jaundice is generally divided into two major categories: physiological jaundice and pathological jaundice. Physiological jaundice is a normal physiological phenomenon. Due to the metabolic characteristics of bilirubin in newborns, approximately 60% of full-term infants and over 80% of preterm infants may develop jaundice 3-5 days after birth, but they are generally in good condition. In full-term infants, jaundice typically resolves within 14 days, while in preterm infants, it may persist for up to 3-4 weeks. Pathological jaundice, on the other hand, is abnormal and is generally associated with the following factors: ① bacterial infections and neonatal sepsis, as well as viral infections such as hepatitis A virus, hepatitis B virus, and cytomegalovirus; ② neonatal hemolytic disease; ③ congenital biliary atresia and biliary cysts; ④ breast milk jaundice, which typically appears 4-7 days after birth, peaks 2-3 weeks later, and the bilirubin level drops within 1-3 days after stopping breastfeeding. If there is no significant decrease after 3 days, breast milk jaundice can be ruled out; ⑤ other factors such as genetic diseases and drug-induced jaundice. Neonatal jaundice should be considered pathological if any of the following conditions are present: jaundice appearing early (within 24 hours after birth); severe jaundice or rapid progression; prolonged duration of jaundice (more than 2 weeks in full-term infants, more than 4 weeks in preterm infants); or jaundice that reappears after initially resolving. Pathological jaundice caused by any reason should be treated by identifying the underlying cause. This is particularly crucial for premature infants within the first week of life, as well as for those with severe hypoxia, acidosis, intracranial lesions, or severe infections. Early and active treatment is essential to prevent adverse outcomes.